· RI legislature · 2025

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT

Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.

Sponsor

Brandon Potter (D-RI)

Introduced

2025-02-26

Policy area

Health

Latest action

03/06/2025 Committee recommended measure be held for further study